Department of Medical Oncology and Haematology, University of Manitoba, Winnipeg, MB.
Curr Oncol. 2011 Dec;18(6):280-4. doi: 10.3747/co.v18i6.841.
Febrile neutropenia is considered an oncologic emergency, for which prompt initiation of antibiotics is essential.
We conducted a retrospective cohort study for the 2006 calendar year involving all adult oncology patients presenting with febrile neutropenia to a regional health authority's emergency departments. The objective was to determine the time from triage to antibiotic administration and its impact on patient outcomes.
We identified 68 patients presenting with febrile neutropenia, most of whom (76%) were seen in tertiary care centers. Of those patients, 65% were triaged to be seen within 15 minutes of arrival in the emergency room; however, the median time to reassessment was 57 minutes. The median time from triage to antibiotic administration was 5 hours (range: 1.23-22.8 hours). No increased risk of death or increased length of hospital stay was associated with delayed antibiotic administration. Older patients and patients without caregiver support were more likely to experience delayed antibiotic administration (odds ratio: 3.8 and 12.7 respectively).
We were not able to show a deleterious effect of delay in antibiotic administration, but our analysis identified several points at which patient flow through the emergency room could be improved.
发热性中性粒细胞减少被认为是一种肿瘤急症,需要迅速开始使用抗生素。
我们进行了一项回顾性队列研究,纳入了 2006 年所有因发热性中性粒细胞减少到区域卫生当局急诊就诊的成年肿瘤患者。目的是确定从分诊到使用抗生素的时间及其对患者结局的影响。
我们共确定了 68 例发热性中性粒细胞减少患者,其中大多数(76%)在三级护理中心就诊。这些患者中,65%在到达急诊室 15 分钟内被分诊为需要立即就诊;但重新评估的中位数时间为 57 分钟。从分诊到使用抗生素的中位数时间为 5 小时(范围:1.23-22.8 小时)。抗生素使用延迟与死亡率增加或住院时间延长无关。老年患者和没有照顾者支持的患者更有可能出现抗生素使用延迟(比值比分别为 3.8 和 12.7)。
我们未能证明抗生素使用延迟有不良影响,但我们的分析确定了急诊室患者流程中可以改进的几个方面。